Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System

Coronary In-stent Restenosis Clinical Trial

Official title:
Best Vascular P000018 Post-approval Study: Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System

Status Recruiting

Clinical Trial Summary

The study will evaluate the long-term safety and efficacy of intravascular beta radiation therapy to treat coronary in-stent restenosis using the Beta-Cath(TM) 3.5F System; data will be collected retrospectively on patients treated with the Beta-Cath™ 3.5F System in routine clinical practice following FDA pre-market approval of the System. Outcomes will be reported up to 5 years following treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Coronary In-stent Restenosis

Clinical Trial Details

NCT number	NCT00852176
Study type	Observational
Source	Best Vascular, Inc.
Contact	Rebecca Torguson, MPH
Phone	202-877-2194
Email	rebecca.torguson@medstar.net
Status	Recruiting
Phase
Start date	May 2009
Completion date	December 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03069066` - Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring Balloon Pre-dilatation (RIBS VI Scoring)	Phase 4
Recruiting	`NCT04213378` - Evaluation of the Efficacy and Safety of a Paclitaxel Eluting PTCA Balloon Catheter in Coronary In-stent Restenosis	Phase 2/Phase 3
Active, not recruiting	`NCT03373695` - A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis	N/A
Not yet recruiting	`NCT02672878` - Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI)	Phase 4